ARK Therapeutics is a Finnish subsidiary of British Ark Therapeutics Group Plc (LSE: AKT). The company is concentrated to manufacturing of adenoviral vectors used in gene therapy, and to study and manufacturing of gene therapies. Ark Therapeutics has a gene therapy center and production facility is Kuopio, Finland.
